Genscript Biotech Corp (OP: GNNSF )

1.250 UNCHANGED

Last Price Updated: 2:29 PM EST, Dec 11, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	1.250
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	1.250
Today's Range	1.250 - 1.250
52wk Range	1.050 - 2.440
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Will Genscript Cash Out Of Legend Biotech In The Face Of Fat Profit Temptation?

August 01, 2024

Key Takeaways: Analysts expect annual sales of Carvykti, Legend Biotech’s core cancer therapy, to peak at $7.3 billion With about $2 billion in cash reserves, Genscript isn’t under pressure to sell its...

Via Benzinga

Week In Review: Korea's SK Biopharma Acquires Radiopharmaceutical In $571 Million Deal

July 20, 2024

In recent news, South Korea’s SK Biopharma in-licensed global rights to a radiopharmaceutical compound developed by Full-Life Technologies of Shanghai in a $571 million deal.

Via Talk Markets

Performance

YTD	-39.61%	-39.61%
1 Month	-8.76%	-8.76%
3 Month	-10.71%	-10.71%
6 Month	-21.88%	-21.88%
1 Year	-48.77%	-48.77%

More News

Week In Review: Structure Reports Efficacy Of Obesity Drug; Raises $476 Million

June 08, 2024

Via Talk Markets

3 DNA Stocks to Buy for the Synthetic Biology Revolution

May 14, 2023

Via InvestorPlace

The Next Big Disruptors? 3 Biotech Stocks Making Headlines.

February 17, 2023

Via InvestorPlace

Week In Review: Mabwell Out-Licenses Rare Disease Drug For $412.5 Million

January 21, 2023

Via Talk Markets

Three Pharma Stocks to Sell Before They Die

December 24, 2022

Via InvestorPlace

Week In Review: Akeso Out-Licenses PD-1/VEGF To Summit In $5 Billion Pact

December 10, 2022

Via Talk Markets

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.